vs
CVR ENERGY INC(CVI)与爱德华生命科学(EW)财务数据对比。点击上方公司名可切换其他公司
CVR ENERGY INC的季度营收约是爱德华生命科学的1.1倍($1.8B vs $1.6B),爱德华生命科学净利率更高(23.1% vs -6.1%,领先29.2%),爱德华生命科学同比增速更快(16.7% vs -7.0%),过去两年爱德华生命科学的营收复合增速更高(9.7% vs -1.4%)
CVR能源是总部位于美国的能源控股企业,主营石油炼制与氮肥制造两大核心业务,生产汽油、柴油、航空燃油及农用化肥等产品,主要面向北美地区的商业、工业及农业客户供货。
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业,专注于人工心脏瓣膜及血流动力学监测领域,其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质,搭配球囊扩张式钴铬合金支架,可通过导管完成植入。
CVI vs EW — 直观对比
营收规模更大
CVI
是对方的1.1倍
$1.6B
营收增速更快
EW
高出23.7%
-7.0%
净利率更高
EW
高出29.2%
-6.1%
两年增速更快
EW
近两年复合增速
-1.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.8B | $1.6B |
| 净利润 | $-110.0M | $380.7M |
| 毛利率 | -3.1% | 78.0% |
| 营业利润率 | -5.3% | 1.8% |
| 净利率 | -6.1% | 23.1% |
| 营收同比 | -7.0% | 16.7% |
| 净利润同比 | -492.9% | 6.8% |
| 每股收益(稀释后) | $-1.09 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CVI
EW
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.8B | $1.6B | ||
| Q3 25 | $1.9B | $1.6B | ||
| Q2 25 | $1.8B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $1.8B | $1.4B | ||
| Q2 24 | $2.0B | $1.4B |
净利润
CVI
EW
| Q1 26 | — | $380.7M | ||
| Q4 25 | $-110.0M | $91.2M | ||
| Q3 25 | $374.0M | $291.1M | ||
| Q2 25 | $-114.0M | $333.2M | ||
| Q1 25 | $-123.0M | $358.0M | ||
| Q4 24 | $28.0M | $385.6M | ||
| Q3 24 | $-124.0M | $3.1B | ||
| Q2 24 | $21.0M | $366.3M |
毛利率
CVI
EW
| Q1 26 | — | 78.0% | ||
| Q4 25 | -3.1% | 78.1% | ||
| Q3 25 | 28.8% | 77.8% | ||
| Q2 25 | -3.7% | 77.5% | ||
| Q1 25 | -5.5% | 78.7% | ||
| Q4 24 | 3.0% | 78.9% | ||
| Q3 24 | -3.9% | 80.6% | ||
| Q2 24 | 2.9% | 79.9% |
营业利润率
CVI
EW
| Q1 26 | — | 1.8% | ||
| Q4 25 | -5.3% | 9.6% | ||
| Q3 25 | 26.3% | 19.8% | ||
| Q2 25 | -5.8% | 26.8% | ||
| Q1 25 | -8.0% | 27.9% | ||
| Q4 24 | 1.1% | 22.6% | ||
| Q3 24 | -6.2% | 25.9% | ||
| Q2 24 | 1.4% | 26.8% |
净利率
CVI
EW
| Q1 26 | — | 23.1% | ||
| Q4 25 | -6.1% | 5.8% | ||
| Q3 25 | 19.2% | 18.7% | ||
| Q2 25 | -6.5% | 21.7% | ||
| Q1 25 | -7.5% | 25.3% | ||
| Q4 24 | 1.4% | 27.8% | ||
| Q3 24 | -6.8% | 226.7% | ||
| Q2 24 | 1.1% | 26.7% |
每股收益(稀释后)
CVI
EW
| Q1 26 | — | $0.66 | ||
| Q4 25 | $-1.09 | $0.16 | ||
| Q3 25 | $3.72 | $0.50 | ||
| Q2 25 | $-1.14 | $0.56 | ||
| Q1 25 | $-1.22 | $0.61 | ||
| Q4 24 | $0.28 | $0.65 | ||
| Q3 24 | $-1.24 | $5.13 | ||
| Q2 24 | $0.21 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $511.0M | — |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $730.0M | — |
| 总资产 | $3.7B | — |
| 负债/权益比越低杠杆越低 | 2.40× | — |
8季度趋势,按日历期对齐
现金及短期投资
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | $511.0M | $4.2B | ||
| Q3 25 | $670.0M | $3.8B | ||
| Q2 25 | $596.0M | $4.1B | ||
| Q1 25 | $695.0M | $3.9B | ||
| Q4 24 | $987.0M | $4.0B | ||
| Q3 24 | $534.0M | $4.4B | ||
| Q2 24 | $586.0M | $2.0B |
总债务
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
股东权益
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | $730.0M | $10.3B | ||
| Q3 25 | $840.0M | $10.2B | ||
| Q2 25 | $466.0M | $10.5B | ||
| Q1 25 | $580.0M | $10.1B | ||
| Q4 24 | $703.0M | $10.0B | ||
| Q3 24 | $675.0M | $9.5B | ||
| Q2 24 | $849.0M | $7.4B |
总资产
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | $3.7B | $13.7B | ||
| Q3 25 | $4.0B | $13.3B | ||
| Q2 25 | $4.0B | $13.5B | ||
| Q1 25 | $4.3B | $13.0B | ||
| Q4 24 | $4.3B | $13.1B | ||
| Q3 24 | $3.9B | $13.0B | ||
| Q2 24 | $4.0B | $10.1B |
负债/权益比
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | 2.40× | — | ||
| Q3 25 | 2.17× | — | ||
| Q2 25 | 3.97× | — | ||
| Q1 25 | 3.29× | — | ||
| Q4 24 | 2.71× | — | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 1.86× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $0 | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | $0 | $450.9M | ||
| Q3 25 | $163.0M | $573.7M | ||
| Q2 25 | $176.0M | $290.2M | ||
| Q1 25 | $-195.0M | $280.4M | ||
| Q4 24 | $98.0M | $-127.5M | ||
| Q3 24 | $48.0M | $351.8M | ||
| Q2 24 | $81.0M | $371.5M |
自由现金流
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | — | $353.5M | ||
| Q3 25 | $125.0M | $516.2M | ||
| Q2 25 | $135.0M | $240.9M | ||
| Q1 25 | $-246.0M | $224.4M | ||
| Q4 24 | $43.0M | $-177.3M | ||
| Q3 24 | $14.0M | $299.9M | ||
| Q2 24 | $38.0M | $286.1M |
自由现金流率
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | — | 22.5% | ||
| Q3 25 | 6.4% | 33.2% | ||
| Q2 25 | 7.7% | 15.7% | ||
| Q1 25 | -14.9% | 15.9% | ||
| Q4 24 | 2.2% | -12.8% | ||
| Q3 24 | 0.8% | 22.1% | ||
| Q2 24 | 1.9% | 20.9% |
资本支出强度
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | 6.2% | ||
| Q3 25 | 2.0% | 3.7% | ||
| Q2 25 | 2.3% | 3.2% | ||
| Q1 25 | 3.1% | 4.0% | ||
| Q4 24 | 2.8% | 3.6% | ||
| Q3 24 | 1.9% | 3.8% | ||
| Q2 24 | 2.2% | 6.2% |
现金转化率
CVI
EW
| Q1 26 | — | — | ||
| Q4 25 | — | 4.94× | ||
| Q3 25 | 0.44× | 1.97× | ||
| Q2 25 | — | 0.87× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 3.50× | -0.33× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | 3.86× | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVI
| Petroleum Segment | $1.6B | 91% |
| Product UAN | $64.0M | 4% |
| Product Ammonia | $51.0M | 3% |
| Renewables Diesel | $27.0M | 1% |
| Product Urea Products | $8.0M | 0% |
| Renewable Fuel Credits | $7.0M | 0% |
EW
暂无分部数据